Malaysia Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners. For the time being, the outlook for the private sector, including for pharmaceutical firms, is good Another populist government,…
See our Cookie Privacy Policy Here